Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.19716350 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.19716350 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.86430676 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.86430676 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.23132478 |
6 | tryptophan catabolic process (GO:0006569) | 5.40366416 |
7 | indole-containing compound catabolic process (GO:0042436) | 5.40366416 |
8 | indolalkylamine catabolic process (GO:0046218) | 5.40366416 |
9 | bile acid biosynthetic process (GO:0006699) | 5.33967935 |
10 | glyoxylate metabolic process (GO:0046487) | 5.26095544 |
11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.24335244 |
12 | kynurenine metabolic process (GO:0070189) | 5.17773735 |
13 | tryptophan metabolic process (GO:0006568) | 5.07547126 |
14 | cysteine metabolic process (GO:0006534) | 5.03142427 |
15 | urea metabolic process (GO:0019627) | 4.79809966 |
16 | urea cycle (GO:0000050) | 4.79809966 |
17 | sulfur amino acid catabolic process (GO:0000098) | 4.75414958 |
18 | high-density lipoprotein particle remodeling (GO:0034375) | 4.68151518 |
19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.67578471 |
20 | lysine metabolic process (GO:0006553) | 4.64347318 |
21 | lysine catabolic process (GO:0006554) | 4.64347318 |
22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.55984011 |
23 | cellular ketone body metabolic process (GO:0046950) | 4.55947623 |
24 | aromatic amino acid family metabolic process (GO:0009072) | 4.53981255 |
25 | nitrogen cycle metabolic process (GO:0071941) | 4.53685695 |
26 | bile acid metabolic process (GO:0008206) | 4.48378519 |
27 | imidazole-containing compound metabolic process (GO:0052803) | 4.43842073 |
28 | negative regulation of fibrinolysis (GO:0051918) | 4.37952040 |
29 | coenzyme catabolic process (GO:0009109) | 4.35509017 |
30 | complement activation, alternative pathway (GO:0006957) | 4.33911340 |
31 | serine family amino acid catabolic process (GO:0009071) | 4.33828160 |
32 | tyrosine metabolic process (GO:0006570) | 4.33775686 |
33 | alpha-amino acid catabolic process (GO:1901606) | 4.33216306 |
34 | regulation of fibrinolysis (GO:0051917) | 4.30860845 |
35 | protein carboxylation (GO:0018214) | 4.28046457 |
36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.28046457 |
37 | regulation of protein activation cascade (GO:2000257) | 4.24766620 |
38 | homocysteine metabolic process (GO:0050667) | 4.19441524 |
39 | amino-acid betaine metabolic process (GO:0006577) | 4.16089518 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.15008084 |
41 | regulation of triglyceride catabolic process (GO:0010896) | 4.12096518 |
42 | reverse cholesterol transport (GO:0043691) | 4.05928334 |
43 | cellular amino acid catabolic process (GO:0009063) | 4.05573164 |
44 | triglyceride homeostasis (GO:0070328) | 4.04622917 |
45 | acylglycerol homeostasis (GO:0055090) | 4.04622917 |
46 | glutamate metabolic process (GO:0006536) | 4.01851899 |
47 | plasma lipoprotein particle remodeling (GO:0034369) | 3.98290258 |
48 | protein-lipid complex remodeling (GO:0034368) | 3.98290258 |
49 | macromolecular complex remodeling (GO:0034367) | 3.98290258 |
50 | regulation of complement activation (GO:0030449) | 3.96284367 |
51 | ketone body metabolic process (GO:1902224) | 3.93707904 |
52 | indolalkylamine metabolic process (GO:0006586) | 3.91331962 |
53 | aldehyde catabolic process (GO:0046185) | 3.85610944 |
54 | short-chain fatty acid metabolic process (GO:0046459) | 3.82012560 |
55 | aspartate family amino acid catabolic process (GO:0009068) | 3.81864074 |
56 | phospholipid efflux (GO:0033700) | 3.81377994 |
57 | cellular modified amino acid catabolic process (GO:0042219) | 3.79944030 |
58 | amine catabolic process (GO:0009310) | 3.79194242 |
59 | cellular biogenic amine catabolic process (GO:0042402) | 3.79194242 |
60 | bile acid and bile salt transport (GO:0015721) | 3.78557050 |
61 | drug catabolic process (GO:0042737) | 3.76628955 |
62 | cofactor catabolic process (GO:0051187) | 3.73829385 |
63 | drug transmembrane transport (GO:0006855) | 3.72845536 |
64 | behavioral response to nicotine (GO:0035095) | 3.69177709 |
65 | acetyl-CoA metabolic process (GO:0006084) | 3.67823815 |
66 | negative regulation of cholesterol transport (GO:0032375) | 3.67144498 |
67 | negative regulation of sterol transport (GO:0032372) | 3.67144498 |
68 | benzene-containing compound metabolic process (GO:0042537) | 3.65368578 |
69 | carboxylic acid catabolic process (GO:0046395) | 3.63570903 |
70 | organic acid catabolic process (GO:0016054) | 3.63570903 |
71 | serine family amino acid metabolic process (GO:0009069) | 3.63055303 |
72 | cholesterol efflux (GO:0033344) | 3.58853788 |
73 | plasma lipoprotein particle clearance (GO:0034381) | 3.58427941 |
74 | cellular glucuronidation (GO:0052695) | 3.58373804 |
75 | arginine metabolic process (GO:0006525) | 3.55384749 |
76 | ethanol oxidation (GO:0006069) | 3.55258501 |
77 | regulation of bile acid biosynthetic process (GO:0070857) | 3.52577654 |
78 | fatty acid beta-oxidation (GO:0006635) | 3.45406500 |
79 | monocarboxylic acid catabolic process (GO:0072329) | 3.45010361 |
80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.44881360 |
81 | fatty acid catabolic process (GO:0009062) | 3.41365487 |
82 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.39409013 |
83 | fatty acid oxidation (GO:0019395) | 3.38788437 |
84 | glycine metabolic process (GO:0006544) | 3.38091913 |
85 | exogenous drug catabolic process (GO:0042738) | 3.37917726 |
86 | urate metabolic process (GO:0046415) | 3.37209137 |
87 | serine family amino acid biosynthetic process (GO:0009070) | 3.35315465 |
88 | 2-oxoglutarate metabolic process (GO:0006103) | 3.33204542 |
89 | lipid oxidation (GO:0034440) | 3.32513896 |
90 | glucuronate metabolic process (GO:0019585) | 3.31594447 |
91 | uronic acid metabolic process (GO:0006063) | 3.31594447 |
92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.29020045 |
93 | plasma lipoprotein particle assembly (GO:0034377) | 3.26958003 |
94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.21302817 |
95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.21302817 |
96 | drug metabolic process (GO:0017144) | 3.21197830 |
97 | NAD biosynthetic process (GO:0009435) | 3.18061022 |
98 | very long-chain fatty acid metabolic process (GO:0000038) | 3.16796108 |
99 | carnitine metabolic process (GO:0009437) | 3.16232015 |
100 | branched-chain amino acid catabolic process (GO:0009083) | 3.15103244 |
101 | cholesterol homeostasis (GO:0042632) | 3.13963810 |
102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.13657387 |
103 | epoxygenase P450 pathway (GO:0019373) | 3.12565565 |
104 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.05147987 |
105 | gamma-aminobutyric acid transport (GO:0015812) | 3.02890170 |
106 | alkaloid metabolic process (GO:0009820) | 3.02054218 |
107 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.96599439 |
108 | oxygen transport (GO:0015671) | 2.92587584 |
109 | synaptic vesicle maturation (GO:0016188) | 2.92341702 |
110 | regulation of synapse structural plasticity (GO:0051823) | 2.89258264 |
111 | response to misfolded protein (GO:0051788) | 2.82890377 |
112 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.74994743 |
113 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.72109644 |
114 | neuronal action potential propagation (GO:0019227) | 2.68335880 |
115 | dendritic spine morphogenesis (GO:0060997) | 2.65987131 |
116 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.64582167 |
117 | alanine transport (GO:0032328) | 2.61434953 |
118 | oxidative demethylation (GO:0070989) | 2.60593713 |
119 | heme metabolic process (GO:0042168) | 2.59849461 |
120 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.57971131 |
121 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.57971131 |
122 | porphyrin-containing compound metabolic process (GO:0006778) | 2.57518850 |
123 | synaptic vesicle exocytosis (GO:0016079) | 2.54731326 |
124 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.53957983 |
125 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.53787771 |
126 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.53787771 |
127 | gas transport (GO:0015669) | 2.52498434 |
128 | neurotransmitter catabolic process (GO:0042135) | 2.52164196 |
129 | neuromuscular process controlling posture (GO:0050884) | 2.47403372 |
130 | tetrapyrrole biosynthetic process (GO:0033014) | 2.47099855 |
131 | reactive oxygen species biosynthetic process (GO:1903409) | 2.46816496 |
132 | creatine metabolic process (GO:0006600) | 2.46389198 |
133 | positive regulation of synapse maturation (GO:0090129) | 2.43795275 |
134 | omega-hydroxylase P450 pathway (GO:0097267) | 2.42896945 |
135 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.42764981 |
136 | heme biosynthetic process (GO:0006783) | 2.41243270 |
137 | positive regulation of fatty acid transport (GO:2000193) | 2.39117511 |
138 | response to dietary excess (GO:0002021) | 2.37802204 |
139 | neuronal ion channel clustering (GO:0045161) | 2.36536800 |
140 | phenylpropanoid metabolic process (GO:0009698) | 2.35672552 |
141 | regulation of sequestering of triglyceride (GO:0010889) | 2.35518630 |
142 | primary amino compound metabolic process (GO:1901160) | 2.35212885 |
143 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.35135710 |
144 | membrane depolarization during action potential (GO:0086010) | 2.31840777 |
145 | iron coordination entity transport (GO:1901678) | 2.31396229 |
146 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.31084712 |
147 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.30788972 |
148 | neurotransmitter secretion (GO:0007269) | 2.29134865 |
149 | glutamate secretion (GO:0014047) | 2.26167501 |
150 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.23864422 |
151 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.22917202 |
152 | regulation of synapse maturation (GO:0090128) | 2.22140425 |
153 | dopamine transport (GO:0015872) | 2.21738720 |
154 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.21344399 |
155 | nucleobase catabolic process (GO:0046113) | 2.21130676 |
156 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.21060502 |
157 | macroautophagy (GO:0016236) | 2.20953664 |
158 | positive regulation of mitochondrial fission (GO:0090141) | 2.19910030 |
159 | neurotransmitter metabolic process (GO:0042133) | 2.19487290 |
160 | synaptic transmission, cholinergic (GO:0007271) | 2.19313390 |
161 | hemoglobin metabolic process (GO:0020027) | 2.18945936 |
162 | ethanol metabolic process (GO:0006067) | 2.17399584 |
163 | regulation of synaptic vesicle transport (GO:1902803) | 2.16237353 |
164 | regulation of neurotransmitter levels (GO:0001505) | 2.13432121 |
165 | regulation of triglyceride metabolic process (GO:0090207) | 2.12832040 |
166 | serotonin metabolic process (GO:0042428) | 2.11950703 |
167 | viral protein processing (GO:0019082) | 2.10531716 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.62041680 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.82843803 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.76836245 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.68682773 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.28689270 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.62690110 |
7 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.51964175 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22770898 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.13079314 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.37329550 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.24621599 |
12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.59134879 |
13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.20008334 |
14 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01283694 |
15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.74012435 |
16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73484280 |
17 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.71660745 |
18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71051792 |
19 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70677073 |
20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.70100309 |
21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.68945447 |
22 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.65808917 |
23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62403884 |
24 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.60965971 |
25 | P68_20966046_ChIP-Seq_HELA_Human | 1.54060067 |
26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53403121 |
27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53215975 |
28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49278062 |
29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.44733092 |
30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38693560 |
31 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.38680201 |
32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38601105 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36047163 |
34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35530752 |
35 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.34328978 |
36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.33664170 |
37 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.33607501 |
38 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.32428749 |
39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32000502 |
40 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31879123 |
41 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30104021 |
42 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29482623 |
43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29478668 |
44 | ERA_21632823_ChIP-Seq_H3396_Human | 1.29019361 |
45 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.29013357 |
46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.26283839 |
47 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.25616748 |
48 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25613699 |
49 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24546779 |
50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22528279 |
51 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.22262711 |
52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22140595 |
53 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.19926512 |
54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19730756 |
55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.18243945 |
56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.17758052 |
57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17259497 |
58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16898641 |
59 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.13620658 |
60 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13487589 |
61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09032134 |
62 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09019531 |
63 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09019531 |
64 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08929320 |
65 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08801563 |
66 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08696104 |
67 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.08090385 |
68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07506322 |
69 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06776203 |
70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05843370 |
71 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.04184169 |
72 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02525466 |
73 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02365584 |
74 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.01262392 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00139061 |
76 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00118252 |
77 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99741396 |
78 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.98863850 |
79 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.98779701 |
80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97824722 |
81 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.97319366 |
82 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97273582 |
83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95370671 |
84 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95157869 |
85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93552909 |
86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92193255 |
87 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91346346 |
88 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90854782 |
89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89229508 |
90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88360189 |
91 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.87959557 |
92 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87919171 |
93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.87645572 |
94 | P300_27268052_Chip-Seq_Bcells_Human | 0.87374944 |
95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86930016 |
96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86406970 |
97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86052328 |
98 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.85757346 |
99 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83465330 |
100 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82371806 |
101 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81683654 |
102 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.81426637 |
103 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.80684854 |
104 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79386821 |
105 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78986533 |
106 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.77996068 |
107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76970226 |
108 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76364983 |
109 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.76148699 |
110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75744735 |
111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75555486 |
112 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75196740 |
113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75196740 |
114 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.74949415 |
115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74553070 |
116 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.73905769 |
117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73287021 |
118 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.73143721 |
119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73092925 |
120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71769881 |
121 | NCOR_22424771_ChIP-Seq_293T_Human | 0.70769296 |
122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70756055 |
123 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69408998 |
124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69321642 |
125 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.69279727 |
126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68960023 |
127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.68694433 |
128 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.68590922 |
129 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.68344236 |
130 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.67294846 |
131 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.66906584 |
132 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.66330087 |
133 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.65758985 |
134 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.65648494 |
135 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.65437265 |
136 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.64982035 |
137 | CBP_21632823_ChIP-Seq_H3396_Human | 0.64017065 |
138 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.62872661 |
139 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.62594747 |
140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62075446 |
141 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.61750600 |
142 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.61750600 |
143 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.61062823 |
144 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.60864480 |
145 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58288823 |
146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.57919729 |
147 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.56758633 |
148 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.56758633 |
149 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.56732497 |
150 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.56587223 |
151 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.56352102 |
152 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.55686747 |
153 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54831808 |
154 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54433691 |
155 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.53847303 |
156 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53584071 |
157 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.53537669 |
158 | KDM2B_26808549_Chip-Seq_REH_Human | 0.53472262 |
159 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.52468778 |
160 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52461519 |
161 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.52271395 |
162 | P300_19829295_ChIP-Seq_ESCs_Human | 0.51230171 |
163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51113195 |
164 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.51041786 |
165 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.50705327 |
166 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.50436626 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.42770369 |
2 | MP0005360_urolithiasis | 6.93270042 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.71698148 |
4 | MP0005365_abnormal_bile_salt | 5.49534314 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.75021040 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.97371768 |
7 | MP0003195_calcinosis | 3.31667674 |
8 | MP0003252_abnormal_bile_duct | 3.27433138 |
9 | MP0010329_abnormal_lipoprotein_level | 3.12192150 |
10 | MP0005332_abnormal_amino_acid | 2.94409533 |
11 | MP0005083_abnormal_biliary_tract | 2.92346667 |
12 | MP0009840_abnormal_foam_cell | 2.56421768 |
13 | MP0001666_abnormal_nutrient_absorption | 2.47288374 |
14 | MP0003646_muscle_fatigue | 2.29182965 |
15 | MP0004859_abnormal_synaptic_plasticity | 2.17585469 |
16 | MP0002876_abnormal_thyroid_physiology | 2.11166990 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.10286057 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.04946009 |
19 | MP0004145_abnormal_muscle_electrophysio | 1.97235063 |
20 | MP0001764_abnormal_homeostasis | 1.92926210 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.92482511 |
22 | MP0005423_abnormal_somatic_nervous | 1.89370404 |
23 | MP0003191_abnormal_cellular_cholesterol | 1.85720526 |
24 | MP0003868_abnormal_feces_composition | 1.81391526 |
25 | MP0000609_abnormal_liver_physiology | 1.79441351 |
26 | MP0003635_abnormal_synaptic_transmissio | 1.72337152 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.69360317 |
28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65089863 |
29 | MP0001486_abnormal_startle_reflex | 1.54936756 |
30 | MP0001905_abnormal_dopamine_level | 1.53911505 |
31 | MP0002063_abnormal_learning/memory/cond | 1.51934016 |
32 | MP0009643_abnormal_urine_homeostasis | 1.49363802 |
33 | MP0003787_abnormal_imprinting | 1.48780601 |
34 | MP0003656_abnormal_erythrocyte_physiolo | 1.46731369 |
35 | MP0002653_abnormal_ependyma_morphology | 1.43851207 |
36 | MP0002254_reproductive_system_inflammat | 1.41154043 |
37 | MP0006036_abnormal_mitochondrial_physio | 1.40284564 |
38 | MP0003878_abnormal_ear_physiology | 1.39190796 |
39 | MP0005377_hearing/vestibular/ear_phenot | 1.39190796 |
40 | MP0002572_abnormal_emotion/affect_behav | 1.38563737 |
41 | MP0005636_abnormal_mineral_homeostasis | 1.35437897 |
42 | MP0004043_abnormal_pH_regulation | 1.34829168 |
43 | MP0002734_abnormal_mechanical_nocicepti | 1.32941330 |
44 | MP0009697_abnormal_copulation | 1.30628402 |
45 | MP0001986_abnormal_taste_sensitivity | 1.29650982 |
46 | MP0005167_abnormal_blood-brain_barrier | 1.28515448 |
47 | MP0002837_dystrophic_cardiac_calcinosis | 1.28024360 |
48 | MP0004885_abnormal_endolymph | 1.27082932 |
49 | MP0003186_abnormal_redox_activity | 1.24009604 |
50 | MP0001970_abnormal_pain_threshold | 1.21886203 |
51 | MP0005451_abnormal_body_composition | 1.20609647 |
52 | MP0002638_abnormal_pupillary_reflex | 1.20460373 |
53 | MP0005535_abnormal_body_temperature | 1.19335754 |
54 | MP0003329_amyloid_beta_deposits | 1.17952378 |
55 | MP0000604_amyloidosis | 1.16326908 |
56 | MP0002822_catalepsy | 1.13741101 |
57 | MP0004742_abnormal_vestibular_system | 1.13107842 |
58 | MP0002067_abnormal_sensory_capabilities | 1.12289457 |
59 | MP0002332_abnormal_exercise_endurance | 1.11075820 |
60 | MP0005647_abnormal_sex_gland | 1.10736531 |
61 | MP0003137_abnormal_impulse_conducting | 1.08369301 |
62 | MP0002078_abnormal_glucose_homeostasis | 1.05589429 |
63 | MP0000749_muscle_degeneration | 1.05283653 |
64 | MP0003172_abnormal_lysosome_physiology | 1.00856222 |
65 | MP0005084_abnormal_gallbladder_morpholo | 0.98899976 |
66 | MP0002557_abnormal_social/conspecific_i | 0.98610835 |
67 | MP0003011_delayed_dark_adaptation | 0.97627433 |
68 | MP0004924_abnormal_behavior | 0.95959570 |
69 | MP0005386_behavior/neurological_phenoty | 0.95959570 |
70 | MP0001529_abnormal_vocalization | 0.95864053 |
71 | MP0008961_abnormal_basal_metabolism | 0.95077286 |
72 | MP0003122_maternal_imprinting | 0.94258668 |
73 | MP0001485_abnormal_pinna_reflex | 0.88898358 |
74 | MP0003123_paternal_imprinting | 0.88855961 |
75 | MP0006035_abnormal_mitochondrial_morpho | 0.88836083 |
76 | MP0005670_abnormal_white_adipose | 0.88017181 |
77 | MP0001756_abnormal_urination | 0.87287518 |
78 | MP0003631_nervous_system_phenotype | 0.86600265 |
79 | MP0009764_decreased_sensitivity_to | 0.85857934 |
80 | MP0000598_abnormal_liver_morphology | 0.85378771 |
81 | MP0009642_abnormal_blood_homeostasis | 0.85346172 |
82 | MP0008569_lethality_at_weaning | 0.84810126 |
83 | MP0005376_homeostasis/metabolism_phenot | 0.84200447 |
84 | MP0000751_myopathy | 0.83933499 |
85 | MP0002066_abnormal_motor_capabilities/c | 0.82937333 |
86 | MP0003879_abnormal_hair_cell | 0.82427313 |
87 | MP0005448_abnormal_energy_balance | 0.81733515 |
88 | MP0002971_abnormal_brown_adipose | 0.81694503 |
89 | MP0002735_abnormal_chemical_nociception | 0.81351600 |
90 | MP0004147_increased_porphyrin_level | 0.79575294 |
91 | MP0005379_endocrine/exocrine_gland_phen | 0.79291472 |
92 | MP0008872_abnormal_physiological_respon | 0.78302477 |
93 | MP0001765_abnormal_ion_homeostasis | 0.77965779 |
94 | MP0005410_abnormal_fertilization | 0.74998714 |
95 | MP0005334_abnormal_fat_pad | 0.74710737 |
96 | MP0005266_abnormal_metabolism | 0.74458846 |
97 | MP0005220_abnormal_exocrine_pancreas | 0.74360508 |
98 | MP0008469_abnormal_protein_level | 0.70851235 |
99 | MP0003690_abnormal_glial_cell | 0.70703330 |
100 | MP0009763_increased_sensitivity_to | 0.70691018 |
101 | MP0004130_abnormal_muscle_cell | 0.70539562 |
102 | MP0009765_abnormal_xenobiotic_induced | 0.69347126 |
103 | MP0003953_abnormal_hormone_level | 0.66560347 |
104 | MP0001661_extended_life_span | 0.66457441 |
105 | MP0008874_decreased_physiological_sensi | 0.66301000 |
106 | MP0002736_abnormal_nociception_after | 0.65967655 |
107 | MP0003638_abnormal_response/metabolism_ | 0.64852493 |
108 | MP0000230_abnormal_systemic_arterial | 0.64789979 |
109 | MP0006276_abnormal_autonomic_nervous | 0.64692626 |
110 | MP0001984_abnormal_olfaction | 0.64005899 |
111 | MP0005645_abnormal_hypothalamus_physiol | 0.63399389 |
112 | MP0000639_abnormal_adrenal_gland | 0.62636239 |
113 | MP0004142_abnormal_muscle_tone | 0.61584609 |
114 | MP0001968_abnormal_touch/_nociception | 0.59367933 |
115 | MP0003959_abnormal_lean_body | 0.58943487 |
116 | MP0005408_hypopigmentation | 0.57770735 |
117 | MP0005551_abnormal_eye_electrophysiolog | 0.57485092 |
118 | MP0001501_abnormal_sleep_pattern | 0.55808821 |
119 | MP0005646_abnormal_pituitary_gland | 0.55181698 |
120 | MP0002090_abnormal_vision | 0.52971672 |
121 | MP0002272_abnormal_nervous_system | 0.51616707 |
122 | MP0009745_abnormal_behavioral_response | 0.51076508 |
123 | MP0002069_abnormal_eating/drinking_beha | 0.50035835 |
124 | MP0002136_abnormal_kidney_physiology | 0.49760462 |
125 | MP0002064_seizures | 0.49647435 |
126 | MP0004270_analgesia | 0.47946758 |
127 | MP0002909_abnormal_adrenal_gland | 0.47015552 |
128 | MP0003880_abnormal_central_pattern | 0.45530453 |
129 | MP0001440_abnormal_grooming_behavior | 0.45382242 |
130 | MP0002733_abnormal_thermal_nociception | 0.44458986 |
131 | MP0001502_abnormal_circadian_rhythm | 0.44005578 |
132 | MP0003075_altered_response_to | 0.43833776 |
133 | MP0002229_neurodegeneration | 0.43715405 |
134 | MP0003633_abnormal_nervous_system | 0.42913517 |
135 | MP0001944_abnormal_pancreas_morphology | 0.42434603 |
136 | MP0000538_abnormal_urinary_bladder | 0.41160774 |
137 | MP0009046_muscle_twitch | 0.40955778 |
138 | MP0002928_abnormal_bile_duct | 0.40937095 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.82404938 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.04957218 |
3 | Deep venous thrombosis (HP:0002625) | 5.49662680 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.29914051 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 5.23114866 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.14963139 |
7 | Xanthomatosis (HP:0000991) | 5.06958580 |
8 | Hyperlipoproteinemia (HP:0010980) | 4.48263907 |
9 | Ketosis (HP:0001946) | 4.34511706 |
10 | Hyperammonemia (HP:0001987) | 4.17930504 |
11 | Complement deficiency (HP:0004431) | 4.07518948 |
12 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.88154073 |
13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.86552451 |
14 | Hypoglycemic coma (HP:0001325) | 3.82199905 |
15 | Hyperglycinuria (HP:0003108) | 3.80987216 |
16 | Hyperglycinemia (HP:0002154) | 3.80732234 |
17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.79848665 |
18 | Hypolipoproteinemia (HP:0010981) | 3.77659742 |
19 | Abnormality of glycine metabolism (HP:0010895) | 3.69339538 |
20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.69339538 |
21 | Myokymia (HP:0002411) | 3.65459944 |
22 | Ketoacidosis (HP:0001993) | 3.65127485 |
23 | Abnormality of methionine metabolism (HP:0010901) | 3.62519149 |
24 | Fat malabsorption (HP:0002630) | 3.59831805 |
25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.54787276 |
26 | Joint hemorrhage (HP:0005261) | 3.53463065 |
27 | Epidermoid cyst (HP:0200040) | 3.48917775 |
28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46652920 |
29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.43344197 |
30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.43071383 |
31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.33472314 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32118660 |
33 | Hypoalphalipoproteinemia (HP:0003233) | 3.21237038 |
34 | Cerebral edema (HP:0002181) | 3.20242810 |
35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.20146435 |
36 | Gout (HP:0001997) | 3.15760764 |
37 | Hyperbilirubinemia (HP:0002904) | 3.15632033 |
38 | Hypochromic anemia (HP:0001931) | 3.01570229 |
39 | Metabolic acidosis (HP:0001942) | 2.97868792 |
40 | Lethargy (HP:0001254) | 2.92928503 |
41 | Dicarboxylic aciduria (HP:0003215) | 2.91099104 |
42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.91099104 |
43 | Abnormal gallbladder morphology (HP:0012437) | 2.90498416 |
44 | Cholecystitis (HP:0001082) | 2.86596245 |
45 | Abnormal gallbladder physiology (HP:0012438) | 2.86596245 |
46 | Delayed CNS myelination (HP:0002188) | 2.84380348 |
47 | Abnormality of purine metabolism (HP:0004352) | 2.83042548 |
48 | Abnormality of complement system (HP:0005339) | 2.83013460 |
49 | Cholelithiasis (HP:0001081) | 2.82864749 |
50 | Abnormality of serum amino acid levels (HP:0003112) | 2.80300492 |
51 | Polyphagia (HP:0002591) | 2.79742028 |
52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.79319958 |
53 | Steatorrhea (HP:0002570) | 2.73441314 |
54 | Hypoglycemic seizures (HP:0002173) | 2.72778171 |
55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.71874779 |
56 | Focal motor seizures (HP:0011153) | 2.61593768 |
57 | Hypercholesterolemia (HP:0003124) | 2.60525192 |
58 | Acute encephalopathy (HP:0006846) | 2.60234793 |
59 | Visual hallucinations (HP:0002367) | 2.60083535 |
60 | Postural instability (HP:0002172) | 2.59864467 |
61 | Generalized aminoaciduria (HP:0002909) | 2.59503367 |
62 | Vomiting (HP:0002013) | 2.44163295 |
63 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.41158498 |
64 | Irritability (HP:0000737) | 2.39277677 |
65 | Acanthocytosis (HP:0001927) | 2.37636424 |
66 | Limb dystonia (HP:0002451) | 2.37552938 |
67 | Brushfield spots (HP:0001088) | 2.36662398 |
68 | Hepatic necrosis (HP:0002605) | 2.35908311 |
69 | Agitation (HP:0000713) | 2.32493550 |
70 | Abnormality of the gallbladder (HP:0005264) | 2.29844861 |
71 | Skin nodule (HP:0200036) | 2.29462595 |
72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28822149 |
73 | Alkalosis (HP:0001948) | 2.26501243 |
74 | Sensorimotor neuropathy (HP:0007141) | 2.24442675 |
75 | Vascular calcification (HP:0004934) | 2.22306026 |
76 | Malnutrition (HP:0004395) | 2.21784466 |
77 | Spontaneous abortion (HP:0005268) | 2.21595934 |
78 | Glycosuria (HP:0003076) | 2.20248719 |
79 | Abnormality of urine glucose concentration (HP:0011016) | 2.20248719 |
80 | Epileptic encephalopathy (HP:0200134) | 2.19688139 |
81 | Mitochondrial inheritance (HP:0001427) | 2.18251623 |
82 | Ventricular fibrillation (HP:0001663) | 2.17351279 |
83 | Febrile seizures (HP:0002373) | 2.17319951 |
84 | Increased purine levels (HP:0004368) | 2.16750380 |
85 | Hyperuricemia (HP:0002149) | 2.16750380 |
86 | Late onset (HP:0003584) | 2.16289002 |
87 | Hepatocellular carcinoma (HP:0001402) | 2.14956213 |
88 | Exercise-induced myalgia (HP:0003738) | 2.13299995 |
89 | Neonatal onset (HP:0003623) | 2.12834786 |
90 | Cerebral palsy (HP:0100021) | 2.12480748 |
91 | Proximal tubulopathy (HP:0000114) | 2.12390061 |
92 | Focal seizures (HP:0007359) | 2.11996156 |
93 | Poikilocytosis (HP:0004447) | 2.11780250 |
94 | Enlarged kidneys (HP:0000105) | 2.11662155 |
95 | Symptomatic seizures (HP:0011145) | 2.11203047 |
96 | Abnormal eating behavior (HP:0100738) | 2.10242255 |
97 | Microcytic anemia (HP:0001935) | 2.10241138 |
98 | Hypochromic microcytic anemia (HP:0004840) | 2.07634441 |
99 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.06301516 |
100 | Osteomalacia (HP:0002749) | 2.05968321 |
101 | Opisthotonus (HP:0002179) | 2.02906877 |
102 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02677010 |
103 | Confusion (HP:0001289) | 2.01861686 |
104 | Systemic lupus erythematosus (HP:0002725) | 2.01541771 |
105 | Polyuria (HP:0000103) | 2.01413421 |
106 | Pancreatitis (HP:0001733) | 1.98827050 |
107 | Hydroxyprolinuria (HP:0003080) | 1.98105656 |
108 | Abnormality of proline metabolism (HP:0010907) | 1.98105656 |
109 | Anxiety (HP:0000739) | 1.97876079 |
110 | Methylmalonic aciduria (HP:0012120) | 1.97088842 |
111 | Acute necrotizing encephalopathy (HP:0006965) | 1.96837846 |
112 | Hyperventilation (HP:0002883) | 1.94912327 |
113 | Molar tooth sign on MRI (HP:0002419) | 1.93991777 |
114 | Abnormality of midbrain morphology (HP:0002418) | 1.93991777 |
115 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92923113 |
116 | Syncope (HP:0001279) | 1.92546455 |
117 | Acute hepatic failure (HP:0006554) | 1.92058863 |
118 | Abnormality of dental color (HP:0011073) | 1.91863681 |
119 | Reticulocytosis (HP:0001923) | 1.91759833 |
120 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91469216 |
121 | Abnormality of alanine metabolism (HP:0010916) | 1.91469216 |
122 | Hyperalaninemia (HP:0003348) | 1.91469216 |
123 | Abnormality of glycolysis (HP:0004366) | 1.91182499 |
124 | Increased serum pyruvate (HP:0003542) | 1.91182499 |
125 | Abnormality of iron homeostasis (HP:0011031) | 1.90748319 |
126 | Lactic acidosis (HP:0003128) | 1.90458931 |
127 | Increased serum ferritin (HP:0003281) | 1.90115949 |
128 | Abnormal urine output (HP:0012590) | 1.89567777 |
129 | Status epilepticus (HP:0002133) | 1.89211411 |
130 | Mitral stenosis (HP:0001718) | 1.89191967 |
131 | Abnormality of binocular vision (HP:0011514) | 1.88910107 |
132 | Diplopia (HP:0000651) | 1.88910107 |
133 | Hepatocellular necrosis (HP:0001404) | 1.88821021 |
134 | Increased muscle lipid content (HP:0009058) | 1.88250961 |
135 | Abnormality of vitamin metabolism (HP:0100508) | 1.88175123 |
136 | Toxemia of pregnancy (HP:0100603) | 1.87551758 |
137 | Cardiovascular calcification (HP:0011915) | 1.87318455 |
138 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.85881040 |
139 | Rickets (HP:0002748) | 1.85432298 |
140 | Muscle fiber inclusion bodies (HP:0100299) | 1.83451704 |
141 | Progressive macrocephaly (HP:0004481) | 1.83260089 |
142 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82538881 |
143 | Abnormality of renal resorption (HP:0011038) | 1.81978022 |
144 | Glomerulonephritis (HP:0000099) | 1.80954880 |
145 | Hypomagnesemia (HP:0002917) | 1.80180081 |
146 | Mutism (HP:0002300) | 1.79556286 |
147 | Retinal atrophy (HP:0001105) | 1.78903512 |
148 | Myoglobinuria (HP:0002913) | 1.78791030 |
149 | Amelogenesis imperfecta (HP:0000705) | 1.77735327 |
150 | Congenital stationary night blindness (HP:0007642) | 1.77418482 |
151 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75289491 |
152 | Myopathic facies (HP:0002058) | 1.74843716 |
153 | Increased CSF lactate (HP:0002490) | 1.74463514 |
154 | Muscle fiber splitting (HP:0003555) | 1.74233242 |
155 | Decreased central vision (HP:0007663) | 1.73456853 |
156 | Absence seizures (HP:0002121) | 1.72420915 |
157 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.72369627 |
158 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.72369627 |
159 | Abnormality of glycolipid metabolism (HP:0010969) | 1.72369627 |
160 | Abnormal EKG (HP:0003115) | 1.71472387 |
161 | Prolonged QT interval (HP:0001657) | 1.70841563 |
162 | Abnormal hemoglobin (HP:0011902) | 1.70705848 |
163 | Generalized tonic-clonic seizures (HP:0002069) | 1.68840078 |
164 | Abnormality of renal excretion (HP:0011036) | 1.68561413 |
165 | Progressive cerebellar ataxia (HP:0002073) | 1.68509144 |
166 | Neurofibrillary tangles (HP:0002185) | 1.68346149 |
167 | Focal dystonia (HP:0004373) | 1.66584900 |
168 | Paralysis (HP:0003470) | 1.66471610 |
169 | Supranuclear gaze palsy (HP:0000605) | 1.65088593 |
170 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.64926386 |
171 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.63916935 |
172 | Abnormal drinking behavior (HP:0030082) | 1.62965207 |
173 | Polydipsia (HP:0001959) | 1.62965207 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.42038676 |
2 | INSRR | 3.30650434 |
3 | ERN1 | 2.82095918 |
4 | NTRK2 | 2.61418182 |
5 | FGFR4 | 2.59905761 |
6 | MAP2K4 | 2.50630542 |
7 | WNK4 | 2.39312361 |
8 | DAPK2 | 2.34733753 |
9 | MAPK15 | 2.20606379 |
10 | SIK1 | 2.20534955 |
11 | PDK3 | 2.19714565 |
12 | PDK4 | 2.19714565 |
13 | WNK3 | 1.99853029 |
14 | ERBB4 | 1.99486121 |
15 | OXSR1 | 1.96033992 |
16 | MARK1 | 1.95773202 |
17 | PINK1 | 1.85875629 |
18 | EPHA4 | 1.77018524 |
19 | PIK3CG | 1.73279489 |
20 | SIK2 | 1.71091754 |
21 | TAOK3 | 1.70349589 |
22 | TLK1 | 1.69771631 |
23 | ADRBK2 | 1.68598090 |
24 | RIPK4 | 1.61848125 |
25 | CAMKK1 | 1.60754836 |
26 | ARAF | 1.60069108 |
27 | MAP3K4 | 1.52110898 |
28 | CASK | 1.43990162 |
29 | CAMKK2 | 1.43475627 |
30 | GRK5 | 1.43111022 |
31 | TAOK1 | 1.37068449 |
32 | MAP4K1 | 1.35146057 |
33 | STK39 | 1.33013119 |
34 | MST1R | 1.31536777 |
35 | MAP2K7 | 1.30804930 |
36 | MUSK | 1.27528588 |
37 | CAMK2G | 1.24774864 |
38 | MAP3K12 | 1.23866927 |
39 | PAK6 | 1.23374372 |
40 | PDK2 | 1.22336929 |
41 | TNK2 | 1.21877044 |
42 | MAPK13 | 1.20615254 |
43 | CAMK1 | 1.20578060 |
44 | NME1 | 1.15370511 |
45 | NTRK3 | 1.14961961 |
46 | SGK223 | 1.12622599 |
47 | SGK494 | 1.12622599 |
48 | BLK | 1.12434246 |
49 | MAP4K2 | 1.08570665 |
50 | MAP2K3 | 1.07286171 |
51 | STK16 | 1.05926085 |
52 | PRKCG | 1.05326262 |
53 | NTRK1 | 1.04671870 |
54 | DYRK1B | 1.04528880 |
55 | TESK2 | 1.04433189 |
56 | MAPK11 | 1.04288881 |
57 | FES | 1.03377175 |
58 | ABL2 | 0.99960097 |
59 | GRK6 | 0.97448251 |
60 | CDK19 | 0.96790709 |
61 | DYRK2 | 0.90229670 |
62 | PRKCZ | 0.90225618 |
63 | PRKAA2 | 0.89564899 |
64 | MYLK | 0.87139552 |
65 | STK11 | 0.86923856 |
66 | FRK | 0.86149612 |
67 | SYK | 0.85342182 |
68 | UHMK1 | 0.84039577 |
69 | FLT3 | 0.82685017 |
70 | CAMK2A | 0.82581863 |
71 | LIMK1 | 0.81628761 |
72 | CAMK4 | 0.80825090 |
73 | MAPKAPK3 | 0.79932990 |
74 | MAP3K7 | 0.78988666 |
75 | STK38L | 0.78889287 |
76 | MARK2 | 0.78005649 |
77 | PTK2B | 0.77728669 |
78 | PRKACG | 0.77298162 |
79 | PDPK1 | 0.77109622 |
80 | BRAF | 0.76231036 |
81 | GRK7 | 0.75834179 |
82 | MAP3K14 | 0.75780982 |
83 | MAP3K3 | 0.75699387 |
84 | CAMK2B | 0.75327865 |
85 | MAP3K11 | 0.73931005 |
86 | MAP3K2 | 0.73404013 |
87 | JAK2 | 0.72993628 |
88 | MAP2K1 | 0.72695165 |
89 | TXK | 0.72099445 |
90 | MINK1 | 0.71227541 |
91 | TRIB3 | 0.69977038 |
92 | KSR2 | 0.69311364 |
93 | DAPK1 | 0.67565527 |
94 | BCR | 0.66252800 |
95 | BMPR2 | 0.64588328 |
96 | MET | 0.64088997 |
97 | PKN1 | 0.63485090 |
98 | MAP3K13 | 0.63400894 |
99 | PRKD2 | 0.61783938 |
100 | MAP2K6 | 0.61004519 |
101 | PRKCQ | 0.59938012 |
102 | MAPK4 | 0.58900274 |
103 | PRKAA1 | 0.58664268 |
104 | PIM2 | 0.58402159 |
105 | PRKACA | 0.57303084 |
106 | CAMK2D | 0.57076087 |
107 | DAPK3 | 0.56751915 |
108 | MAPK12 | 0.56207915 |
109 | SGK1 | 0.55374220 |
110 | MAP3K1 | 0.54687238 |
111 | PDK1 | 0.54071654 |
112 | PRKCA | 0.53298900 |
113 | AKT3 | 0.53224628 |
114 | PIK3CA | 0.53182385 |
115 | PRKCH | 0.53081244 |
116 | IRAK1 | 0.52935103 |
117 | OBSCN | 0.52355798 |
118 | TESK1 | 0.51947272 |
119 | STK38 | 0.51910575 |
120 | RPS6KA2 | 0.51686865 |
121 | ADRBK1 | 0.51321161 |
122 | PTK2 | 0.51283509 |
123 | TBK1 | 0.50242224 |
124 | PRKG1 | 0.50018289 |
125 | CSNK1G2 | 0.49471551 |
126 | PAK3 | 0.47691438 |
127 | SGK2 | 0.47409672 |
128 | TAOK2 | 0.47094893 |
129 | MAP3K5 | 0.45734552 |
130 | EPHB1 | 0.44717576 |
131 | PRKCE | 0.42849647 |
132 | MAPKAPK5 | 0.42470742 |
133 | TYK2 | 0.42361869 |
134 | IRAK2 | 0.40092832 |
135 | FER | 0.39390571 |
136 | GRK1 | 0.37911979 |
137 | PRKD3 | 0.36789571 |
138 | PBK | 0.36781583 |
139 | PTK6 | 0.36528498 |
140 | PHKG2 | 0.36473562 |
141 | PHKG1 | 0.36473562 |
142 | MAP2K2 | 0.35849030 |
143 | MAPK7 | 0.34528666 |
144 | DYRK1A | 0.34510269 |
145 | CDK5 | 0.33498549 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.99276784 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44877341 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86550647 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.78908155 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.70516406 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61697620 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52778886 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51066044 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50995676 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37927097 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31574334 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.30721530 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23802852 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.10130912 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.09657363 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00097862 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99147903 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98845752 |
19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90992662 |
20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80285490 |
21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78132017 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72573915 |
23 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71145123 |
24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70241978 |
25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70038788 |
26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68779666 |
27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.67886177 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63166435 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60992034 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58938918 |
31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57620559 |
32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55802666 |
33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52111553 |
34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45671821 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.44879579 |
36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41587136 |
37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40841042 |
38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39984498 |
39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37601090 |
40 | Morphine addiction_Homo sapiens_hsa05032 | 1.36925372 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35299047 |
42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32965172 |
43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29039830 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28794966 |
45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27946621 |
46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26599033 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22769007 |
48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19985034 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19218909 |
50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18562646 |
51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18026273 |
52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12677289 |
53 | ABC transporters_Homo sapiens_hsa02010 | 1.08280647 |
54 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07789827 |
55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07680263 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07118075 |
57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06261269 |
58 | Phototransduction_Homo sapiens_hsa04744 | 1.03427388 |
59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01315006 |
60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00536571 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95626116 |
62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95435418 |
63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94386388 |
64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93970069 |
65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.92737377 |
66 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91629886 |
67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90788073 |
68 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89992105 |
69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87688319 |
70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77395069 |
71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74832031 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74682589 |
73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73794149 |
74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72941694 |
75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.72254414 |
76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70895982 |
77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67324753 |
78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.65451828 |
79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64145381 |
80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64095397 |
81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62817685 |
82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62392748 |
83 | Salivary secretion_Homo sapiens_hsa04970 | 0.61917471 |
84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.61809605 |
85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56402088 |
86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56073606 |
87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56044914 |
88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53541030 |
89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49144397 |
90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48145066 |
91 | Taste transduction_Homo sapiens_hsa04742 | 0.47865422 |
92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47796644 |
93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47542412 |
94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45348915 |
95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44356614 |
96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44319064 |
97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43940839 |
98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43877268 |
99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42634705 |
100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41737942 |
101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40729800 |
102 | Lysosome_Homo sapiens_hsa04142 | 0.39309806 |
103 | Lysine degradation_Homo sapiens_hsa00310 | 0.37627774 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.29793922 |
105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29667684 |
106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29660963 |
107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27154939 |
108 | Huntingtons disease_Homo sapiens_hsa05016 | 0.24723452 |
109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22509361 |
110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22017404 |
111 | Protein export_Homo sapiens_hsa03060 | 0.21911625 |
112 | GABAergic synapse_Homo sapiens_hsa04727 | 0.13454310 |
113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13033383 |
114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10710338 |
115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.10115230 |
116 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.08590207 |
117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.06479183 |
118 | Insulin secretion_Homo sapiens_hsa04911 | 0.05754689 |
119 | Insulin resistance_Homo sapiens_hsa04931 | 0.04675922 |
120 | Nicotine addiction_Homo sapiens_hsa05033 | 0.01811222 |
121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.01677656 |
122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00974121 |
123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00301586 |
124 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | -0.0779302 |
125 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0758631 |
126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0391766 |
127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0364691 |
128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0015708 |